Evidence map›Paper›PMID 26056442›Full record

ArticleInternational journal of nanomedicine2015

Effects of PVA coated nanoparticles on human immune cells.

Cindy Strehl, Timo Gaber, Lionel Maurizi, Martin Hahne, Roman Rauch, Paula Hoff, Thomas Häupl, Margarethe Hofmann-Amtenbrink, A Robin Poole, Heinrich Hofmann and 1 more

Open access · goldAbstract read
In one paragraph

Article in International journal of nanomedicine, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 37 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Review
  9. Article
  10. Review
  11. Review
  12. The effect of core and lanthanide ion dopants in sodium fluoride-based nanocrystals on phagocytic activity of human blood leukocytes.Journal of nanoparticle research : an interdisciplinary forum for nanoscale science and technology · 2017
    Article
  13. Article
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 3 countries.

Cindy StrehlDepartment of Rheumatology and Clinical Immunology, Charité Universitätsmedizin Berlin, Berlin, Germany ; German Rheumatism Research Centre (DRFZ), Berlin, Germany.
Timo GaberDepartment of Rheumatology and Clinical Immunology, Charité Universitätsmedizin Berlin, Berlin, Germany ; German Rheumatism Research Centre (DRFZ), Berlin, Germany ; Berlin-Brandenburg Center for Regenerative Therapies (BCRT), Berlin, Germany.
Lionel MauriziPowder Technology Laboratory, Ecole Polytechnique Federale de Lausanne (EPFL), Lausanne, Switzerland.
Martin HahneDepartment of Rheumatology and Clinical Immunology, Charité Universitätsmedizin Berlin, Berlin, Germany ; German Rheumatism Research Centre (DRFZ), Berlin, Germany.
Roman RauchDepartment of Rheumatology and Clinical Immunology, Charité Universitätsmedizin Berlin, Berlin, Germany ; German Rheumatism Research Centre (DRFZ), Berlin, Germany.
Paula HoffDepartment of Rheumatology and Clinical Immunology, Charité Universitätsmedizin Berlin, Berlin, Germany ; German Rheumatism Research Centre (DRFZ), Berlin, Germany ; Berlin-Brandenburg Center for Regenerative Therapies (BCRT), Berlin, Germany.
Thomas HäuplDepartment of Rheumatology and Clinical Immunology, Charité Universitätsmedizin Berlin, Berlin, Germany.
Margarethe Hofmann-AmtenbrinkMatSearch Consulting Hofmann, Pully-Lausanne, Switzerland.
A Robin PooleDepartment of Surgery, McGill University, Montreal, QC, Canada.
Heinrich HofmannPowder Technology Laboratory, Ecole Polytechnique Federale de Lausanne (EPFL), Lausanne, Switzerland.
Frank ButtgereitDepartment of Rheumatology and Clinical Immunology, Charité Universitätsmedizin Berlin, Berlin, Germany ; German Rheumatism Research Centre (DRFZ), Berlin, Germany ; Berlin-Brandenburg Center for Regenerative Therapies (BCRT), Berlin, Germany.
Charité - Universitätsmedizin Berlin · DEÉcole Polytechnique Fédérale de Lausanne · CHMcGill University · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Nanotechnology provides new opportunities in human medicine, mainly for diagnostic and therapeutic purposes. The autoimmune disease rheumatoid arthritis (RA) is often diagnosed after irreversible joint structural damage has occurred. There is an urgent need for a very early diagnosis of RA, which can be achieved by more sensitive imaging methods. Superparamagnetic iron oxide nanoparticles (SPION) are already used in medicine and therefore represent a promising tool for early diagnosis of RA. The focus of our work was to investigate any potentially negative effects resulting from the interactions of newly developed amino-functionalized amino-polyvinyl alcohol coated (a-PVA) SPION (a-PVA-SPION), that are used for imaging, with human immune cells. We analyzed the influence of a-PVA-SPION with regard to cell survival and cell activation in human whole blood in general, and in human monocytes and macrophages representative of professional phagocytes, using flow cytometry, multiplex suspension array, and transmission electron microscopy. We found no effect of a-PVA-SPION on the viability of human immune cells, but cytokine secretion was affected. We further demonstrated that the percentage of viable macrophages increased on exposure to a-PVA-SPION. This effect was even stronger when a-PVA-SPION were added very early in the differentiation process. Additionally, transmission electron microscopy analysis revealed that both monocytes and macrophages are able to endocytose a-PVA-SPION. Our findings demonstrate an interaction between human immune cells and a-PVA-SPION which needs to be taken into account when considering the use of a-PVA-SPION in human medicine.

Indexed as

Arthritis, RheumatoidCell SurvivalCytokinesEndocytosisHumansMacrophagesMagnetite NanoparticlesMicroscopy, Electron, TransmissionMonocytesPolyvinyl AlcoholToxicity TestsCytokinesMagnetite NanoparticlesPolyvinyl Alcoholcell viabilitycytokinemacrophagemonocytenanoparticle

Identifiers

PMID26056442
PMCPMC4431506
OpenAlexW1828565950

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.